EcoDrugPlus

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSTTRG00000000651
Gene Symbol: GUCY1A1
1 Cross references
202 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSTTRG00000013659
Gene Symbol: GUCY1A2
1 Cross references
202 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSTTRG00000000652
Gene Symbol: GUCY1B1
1 Cross references
209 Possible Orthologues:

Heat Shock Protein 90 Alpha Family Class A Member 1

Ensembl ID : ENSTTRG00000004558
Gene Symbol: HSP90AA1
1 Cross references
207 Possible Orthologues:

Histamine Receptor H2

Ensembl ID : ENSTTRG00000000456
Gene Symbol: HRH2
3 Cross references
249 Possible Orthologues:

Histamine Receptor H3

Ensembl ID : ENSTTRG00000011074
Gene Symbol: HRH3
1 Cross references
117 Possible Orthologues:

Histamine Receptor H4

Ensembl ID : ENSTTRG00000017090
Gene Symbol: HRH4
1 Cross references
103 Possible Orthologues:

Histone Deacetylase 1

Ensembl ID : ENSTTRG00000001613
Gene Symbol: HDAC1
1 Cross references
267 Possible Orthologues:

Histone Deacetylase 10

Ensembl ID : ENSTTRG00000012295
Gene Symbol: HDAC10
1 Cross references
181 Possible Orthologues:

Histone Deacetylase 11

Ensembl ID : ENSTTRG00000011189
Gene Symbol: HDAC11
1 Cross references
197 Possible Orthologues:

Histone Deacetylase 2

Ensembl ID : ENSTTRG00000015043
Gene Symbol: HDAC2
1 Cross references
199 Possible Orthologues:

Histone Deacetylase 3

Ensembl ID : ENSTTRG00000013734
Gene Symbol: HDAC3
1 Cross references
156 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).